𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: androgen-receptor cofactors and bypass pathways

✍ Scribed by Joanne Edwards; John M.S. Bartlett

Book ID
109051821
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
404 KB
Volume
95
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Amplification of the androgen receptor g
Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer
✍ Koivisto, Pasi A.; Rantala, Immo πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 257 KB πŸ‘ 2 views

p53 protein expression of 30 hormone-refractory locally recurrent prostate cancers was compared with their matched untreated primary tumour specimens. In addition, androgen receptor (AR) gene amplification and p53 protein immunostaining were compared. p53 positivity increased during hormonal therapy

17Ξ²-estradiol differentially regulates a
17Ξ²-estradiol differentially regulates androgen-responsive genes through estrogen receptor-Ξ²- and extracellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells
✍ Yoko Takahashi; Susan N. Perkins; Stephen D. Hursting; Thomas T.Y. Wang πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 191 KB

## Abstract The molecular mechanism underlying the actions of estrogens in normal prostate physiology and prostate cancer development remains unclear. In the present study we tested the hypothesis that estrogens modulate androgen‐dependent events in prostate cells by examining the effects of 17β‐es